11TEN, Konika Minolta, and Emory Healthcare discuss the challenges of Realizing Innovation

To elevate the conversation and learnings around the initial problems facing health care and the innovation needed to solve them, the Emory Healthcare Innovation Hub launched the Realizing Innovation Event Series.

Produced by 11|TEN Innovation Partners, the Series kicked off this inaugural event at Emory’s Convocation Hall on July 10, 2019, with Hub partner Konica Minolta Healthcare. This event included a fireside chat on the future of personalized medicine and featured Scott D. Boden, M.D., Vice President of business innovation, Emory Healthcare, and David Widmann, President and CEO, Konica Minolta Healthcare Americas. Dr. Boden and Mr. Widmann shared insights and projects underway to accelerate innovation in personalized medicine, image analytics, and genetics. Will ElLaissi, Managing Director of the Emory Healthcare Innovation Hub, kicked off and closed the event, while James Lewis, CEO of 11|TEN Innovation Partners moderated the chat.

This strategic partnership through the Emory Healthcare Innovation Hub combines the sophisticated capabilities of Konica Minolta’s healthcare technology, uniquely integrating medical imaging, informatics, and genetics with the world-class academic research capabilities of Emory’s Woodruff Health Sciences Center. It is focused on advancing consumer-driven healthcare solutions, and the development of evidence-based, data-driven healthcare applications through a collaborative environment. Initially, Konica Minolta and the Emory Healthcare Innovation Hub will focus on solutions that enhance diagnostic capabilities for clinicians and their patients in orthopedics and sports medicine, breast imaging, and personalized medicine.

Emory Healthcare will be the first clinical site to implement Konica Minolta‘s Dynamic Digital Radiography (DDR) for orthopedics. DDR is an enhanced X-ray technology that enables clinicians to observe the dynamic motion of anatomical structures over time, enhancing diagnostic capabilities. Exa® Mammo, a PACS designed specifically for breast imaging studies, will be implemented in the oncology department to provide rapid viewing of breast images, improving clinical workflow for the breast oncologists. The organizations will also explore new solutions and approaches in precision medicine and the further integration of genetics in care delivery with Ambry Genetics, a Konica Minolta company.